Why the study?
Atrial giant cell myocarditis has been recognized as a distinct clinicopathological entity from classical giant cell myocarditis, but understanding of its characteristics, triggers, diagnosis, and management remains limited.
Population
1 patient with atrial giant cell myocarditis and a history of renal abscess
Design
Case report and literature review
Authors
Loading...
Recognition of atrial GCM as distinct from classical disease may refine biopsy interpretation; leaves open dedicated outcome studies.
Atrial giant cell myocarditis is a distinct clinicopathological entity characterized by preserved left ventricular function, atrial arrhythmias, and a more benign prognosis than classical giant cell myocarditis.
Tang et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: